Trial record 1 of 31 for:    font
Previous Study | Return to List | Next Study

Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial

This study has been completed.
University of Michigan
The Cleveland Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
New York University School of Medicine Identifier:
First received: December 22, 2008
Last updated: April 10, 2014
Last verified: April 2014